Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Current Deferred Revenue (2018 - 2019)

Lemaitre Vascular (LMAT) has disclosed Current Deferred Revenue for 2 consecutive years, with $188000.0 as the latest value for Q2 2019.

  • On a quarterly basis, Current Deferred Revenue fell 80.23% to $188000.0 in Q2 2019 year-over-year; TTM through Jun 2019 was $188000.0, a 80.23% decrease, with the full-year FY2018 number at $552000.0, changed N/A from a year prior.
  • Current Deferred Revenue was $188000.0 for Q2 2019 at Lemaitre Vascular, down from $368000.0 in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $951000.0 in Q2 2018 to a low of $188000.0 in Q2 2019.